Cardiology Familial Hypercholesterolemia: eLearning program Dr. Robert A. Hegele — Length: 34:37 Familial Hypercholesterolemia: Preventing Cardiovascular Events Watch Presentation
gastroenterology Bile Acid Diarrhea: eLearning program Dr. Alan Barkun — Length: 08:43 Bile Acid Diarrhea (BAD): Treatable But Under Recognized Watch Presentation
rheumatology American College of Rheumatology (ACR) 2015 Congress November 6-11, 2015 — San Francisco, California Expansion in Biologic Option Critical For Non-Responders to TNF Inhibitors Download 2 PowerPoint slides
Cardiology American Heart Association (AHA) Scientific Sessions 2015 November 7-11, 2015 — Orlando, Florida PCSK9 Inhibitors Show Similar Efficacy in Diabetics as in Other High-Risk Groups Download 3 PowerPoint slides
Cardiology American Heart Association (AHA) Scientific Sessions 2015 November 7-11, 2015 — Orlando, Florida SPRINT Trial: Mortality Benefit Associated with Intensive Blood Pressure Control Download 7 PowerPoint slides
Respirology CHEST Annual Meeting 2015 October 24-28, 2015 — Montreal, Quebec One Size Does Not Fit All in the Treatment of Asthma Download 2 PowerPoint slides
Cardiology 2015 Canadian Cardiovascular Congress (CCC) October 24-27, 2015 — Toronto, Ontario Debating North American Cholesterol Guidelines and the Role of PCSK9 Inhibitors Download 1 PowerPoint slides
oncology 2015 European Cancer Congress (ECC) September 26-29, 2015 — Vienna, Austria TKI Targeted at T790M Lung Cancer Mutations Yields High Rate of Disease Control Download 1 PowerPoint slides
Respirology European Respiratory Society (ERS) International Congress 2015 September 26-30, 2015 — Amsterdam, The Netherlands Concrete Steps Taken to Base Severe Asthma Treatment on Molecular Rather than Clinical Phenotypes Download 3 PowerPoint slides
Cardiology ESC Congress 2015 August 29-September 2, 2015 — London, UK PCSK9 Inhibitor Achieves Persistent LDL-C Control and Sustained Safety in a Challenging Population Download 3 PowerPoint slides
Cardiology Pursuing the Next Step in Reduction of Residual CV Risk Chapter 1: Lipid Lowering: The Road to Current Treatment Guidelines Jean C. Grégoire, MD, FRCPC, FACC Cardiologist Montreal Heart Institute Associate Professor of Medicine Université de Montréal, Montreal, Quebec Download 18 PowerPoint slides
Cardiology Pursuing the Next Step in Reduction of Residual CV Risk Chapter 2: The Development and Promise of PCSK9 Inhibitors Nabil G. Seidah, OC, OQ, PhD, FRSC Director, Laboratory of Biochemical Neuroendocrinology Clinical Research Institute of Montreal, Canada Research Chair in Proteolysis Montreal, QC Download 18 PowerPoint slides